M. Yldau van der Ende

M. Yldau van der Ende

Auto-generated profile, based on publicly available information

M. Yldau van der Ende

University of Groningen, University Medical Center Groningen, the Department of Cardiology, Groningen, the Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in International Journal of Cardiology
Verified
Journal Article
Open access
MEM. Yldau van der Ende
M. Yldau van der Ende
MHMinke H.T. Hartman
Minke H.T. Hartman
YHYanick Hagemeijer
Yanick Hagemeijer
LMLaura M.G. Meems
Laura M.G. Meems
HVHendrik Sierd de Vries
Hendrik Sierd de Vries
PHPim van der Harst
Pim van der Harst
The LifeLines Cohort Study is a large three-generation prospective study and Biobank. Recruitment and data collection started in 2006 and follow-up is planned for 30years. The central aim of LifeLines is to understand healthy ageing in the 21st century. Here, the study design, methods, baseline and major cardiovascular phenotypes of the LifeLines Cohort Study are presented. Baseline cardiovascular phenotypes were defined in 9700 juvenile (8-18years) and 152,180 adult (≥18years) participants. Cardiovascular disease (CVD) was defined using ICD-10 criteria. At least one cardiovascular risk factor was present in 73% of the adult participants. The prevalence, adjusted for the Dutch population, was determined for risk factors (hypertension (33%), hypercholesterolemia (19%), diabetes (4%), overweight (56%), and current smoking (19%)) and CVD (myocardial infarction (1.8%), heart failure (1.0%), and atrial fibrillation (1.3%)). Overall CVD prevalence increased with age from 9% in participants<65years to 28% in participants≥65years. Of the participants with hypertension, hypercholesterolemia and diabetes, respectively 75%, 96% and 41% did not receive preventive pharmacotherapy. The contemporary LifeLines Cohort Study provides researchers with unique and novel opportunities to study environmental, phenotypic, and genetic risk factors for CVD and is expected to improve our knowledge on healthy ageing. In this contemporary Western cohort we identified a remarkable high percentage of untreated CVD risk factors suggesting that not all opportunities to reduce the CVD burden are utilised.

27 July 2019 in Current Cardiology Reports
Verified
Journal Article
Open access
PDF file
ASAbdullah Said
Abdullah Said
YVYordi J. van de Vegte
Yordi J. van de Vegte
Muhammad Mobeen ZafarMuhammad Mobeen Zafar
Muhammad Mobeen Zafar
MEM. Yldau van der Ende
M. Yldau van der Ende
GRGhazala Kaukab Raja
Ghazala Kaukab Raja
PHPim van der Harst
Pim van der Harst
Purpose of the Review To summarize current knowledge on interactions between genetic variants and lifestyle factors (G×L) associated with the development of coronary artery disease (CAD) and prioritize future research. Recent Findings Genetic risk and combined lifestyle factors and behaviors have a log-additive effect on the risk of developing CAD. Summary First, we describe genetic and lifestyle factors associated with CAD and then focus on G×L interactions. The majority of G×L interaction studies are small-scale candidate gene studies that lack replication and therefore provide spurious results. Only a few studies, of which most use genetic risk scores or genome-wide approaches to test interactions, are robust in number and analysis strategy. These studies provide evidence for the existence of G×L interactions in the development of CAD. Further G×L interactions studies are important as they contribute to our understanding of disease pathophysiology and possibly provide insights for improving interventions or personalized recommendations.

12 June 2017 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
MEM. Yldau van der Ende
M. Yldau van der Ende
JSJoylene E. Siland
Joylene E. Siland
HSHarold Snieder
Harold Snieder
PHPim van der Harst
Pim van der Harst
MRMichiel Rienstra
Michiel Rienstra
Background: Our aim is to present average values and prevalence of electrocardiographic (ECG) abnormalities among the general Dutch population in the LifeLines Cohort.Hypothesis: The ECG values previously studied in the Caucasian population of smaller cohorts will be confirmed with ECG data from LifeLines.Methods: ECG data of 152 180 individuals age 18 to 93 years were available. Individuals with cardiovascular risk factors were excluded to analyze the healthy population. Average values of the ECG for the healthy population were presented as means with 95% and 99% confidence intervals and as medians with first and 99th percentiles.Results: Median heart rate was highest in the youngest and oldest individuals of the healthy population. Median duration of P wave, PQ interval, and QRS duration were longer in males compared with females. In contrast, median QT interval corrected for heart rate was higher in females. In general, the above‐mentioned parameters increased with age. The prevalences of ECG abnormalities adjusted for the Dutch population were 0.9% for atrial fibrillation or flutter, 1.4% for premature atrial complexes, 0.5% for myocardial infarction, 2.1% for ventricular premature complexes, 1.0% for left ventricular hypertrophy, 8.1% for P‐R interval >200 ms, and 0.8% for bundle branch block.Conclusions: Our study provides an overview of average values and ECG abnormalities and confirms data of previous smaller studies. In addition, we evaluate the age‐ and sex‐dependent normal limits of the P wave and QRS duration and confirm in detail the frontal plane QRS‐T angle on the ECG.

7 April 2017 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
THTom Hendriks
Tom Hendriks
MHMinke H. T. Hartman
Minke H. T. Hartman
PVPieter J. J. Vlaar
Pieter J. J. Vlaar
NPNiek Prakken
Niek Prakken
YEYldau M. Y. van der Ende
Yldau M. Y. van der Ende
PHPim van der Harst
Pim van der Harst
Adverse left ventricular (LV) remodeling after acute ST-elevation myocardial infarction (STEMI) is associated with morbidity and mortality. We studied clinical, biochemical and angiographic determinants of LV end diastolic volume index (LVEDVi), end systolic volume index (LVESVi) and mass index (LVMi) as global LV remodeling parameters 4 months after STEMI, as well as end diastolic wall thickness (EDWT) and end systolic wall thickness (ESWT) of the non-infarcted myocardium, as compensatory remote LV remodeling parameters. Data was collected in 271 patients participating in the GIPS-III trial, presenting with a first STEMI. Laboratory measures were collected at baseline, 2 weeks, and 6–8 weeks. Cardiovascular magnetic resonance imaging (CMR) was performed 4 months after STEMI. Linear regression analyses were performed to determine predictors. At baseline, patients were 21% female, median age was 58 years. At 4 months, mean LV ejection fraction (LVEF) was 54 ± 9%, mean infarct size was 9.0 ± 7.9% of LVM. Strongest univariate predictors (all p < 0.001) were peak Troponin T for LVEDVi (R2 = 0.26), peak CK-MB for LVESVi (R2 = 0.41), NT-proBNP at 2 weeks for LVMi (R2 = 0.24), body surface area for EDWT (R2 = 0.32), and weight for ESWT (R2 = 0.29). After multivariable analysis, cardiac biomarkers remained the strongest predictors of LVMi, LVEDVi and LVESVi. NT-proBNP but none of the acute cardiac injury biomarkers were associated with remote LV wall thickness. Our analyses illustrate the value of cardiac specific biochemical biomarkers in predicting global LV remodeling after STEMI. We found no evidence for a hypertrophic response of the non-infarcted myocardium.

1 September 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
MEM. Yldau van der Ende
M. Yldau van der Ende
MHMinke H.T. Hartman
Minke H.T. Hartman
RSRemco A.J. Schurer
Remco A.J. Schurer
HWHindrik W. van der Werf
Hindrik W. van der Werf
ELErik Lipšic
Erik Lipšic
PHPim van der Harst
Pim van der Harst

19 July 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
DTDaan Ties
Daan Ties
YEYldau M van der Ende
Yldau M van der Ende
GPGabija Pundziute
Gabija Pundziute
YSYvonne T van der Schouw
Yvonne T van der Schouw
MBMichiel L Bots
Michiel L Bots
PHPim van der Harst
Pim van der Harst
Aims: To evaluate the ability of Systematic COronary Risk Estimation 2 (SCORE2) and other pre-screening methods to identify individuals with high coronary artery calcium score (CACS) in the general population. Methods and results: Computed tomography-based CACS quantification was performed in 6530 individuals aged 45 years or older from the general population. Various pre-screening methods to guide referral for CACS were evaluated. Miss rates for high CACS (CACS ≥300 and ≥100) were evaluated for various pre-screening methods: moderate (≥5%) and high (≥10%) SCORE2 risk, any traditional coronary artery disease (CAD) risk factor, any Risk Or Benefit IN Screening for CArdiovascular Disease (ROBINSCA) risk factor, and moderately (>3 mg/24 h) increased urine albumin excretion (UAE). Out of 6530 participants, 643 (9.8%) had CACS ≥300 and 1236 (18.9%) had CACS ≥100. For CACS ≥300 and CACS ≥100, miss rate was 32 and 41% for pre-screening by moderate (≥5%) SCORE2 risk and 81 and 87% for high (≥10%) SCORE2 risk, respectively. For CACS ≥300 and CACS ≥100, miss rate was 8 and 11% for pre-screening by at least one CAD risk factor, 24 and 25% for at least one ROBINSCA risk factor, and 67 and 67% for moderately increased UAE, respectively. Conclusion: Many individuals with high CACS in the general population are left unidentified when only performing CACS in case of at least moderate (≥5%) SCORE2, which closely resembles current clinical practice. Less stringent pre-screening by presence of at least one CAD risk factor to guide CACS identifies more individuals with high CACS and could improve CAD prevention.